Navigation Links
2010 AIDS Target May Misfire, Warns United Nations

With just a few days more for the review conference on the UN five year plan on AIDS, the feelers received from the UN is certainly not encouraging. // The United Nations has made no bones that the global effort to catch up with the epidemic is lacking in many areas, which might deter the achievement of the 2010 target.

The UN study on the five-year plan calls for a global integrated effort that is powerful and well administered to meet the 2010 target.

It is estimated that nearly 25 million people in the last 25 years have died of AIDS and another 40 million people are presently infected. Sadly, inspite of all the concerted efforts to curb the spread of AIDS, the epidemic has always taken the upper hand, leaving many patients in jeopardy with lack of sufficient medical infrastructure to cater to the AIDS cases.


'"/>




Page: 1

Related medicine news :

1. Target for obesity treatment
2. Gel Offers A More Targeted Approach
3. In Search Of A New Drug To Target Cholesterol
4. In Search Of A New Drug To Target Cholesterol
5. Target of diabetes type 1 identified
6. Gene Target For Tuberculosis Identified
7. New Vaccine Targeted At Effective Treatment Against Tuberculosis
8. Novel Technique For Targeting Small-Cell Lung Cancer
9. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
10. Doctors, Pharma Companies Targeted By CBI Raids
11. Research Targets treatment for dementia and brain injuries
Post Your Comments:
(Date:12/2/2008)... , SAN DIEGO, Dec. 2 Strolle...owing exercise program for new moms and their babi...aby care for more than 40 years, has signed on as ... The new partnership will strengthen the companies...d moms. , , "We are thrilled to have Pamper...
(Date:12/2/2008)...omized Comparator Study to Evaluate Efficacy of Co... , WOODCLIFF LAKE, N.J., Dec. 2 ...d that it plans to initiate the first clinical tri...ne for injection) compared to Vidaza(R) (azacitidi...diate-2 or high-risk myelodysplastic syndromes (MD...
(Date:12/2/2008)...VILLE, Tenn., Dec. 2 Emdeon, a lea...ment solutions for the healthcare industry,annou...nitor business,efficiency in healthcare. Emdeon u...( www.ushealthcareindex.com ) to establish a natio...sition from a paper-based and phone-based,system ...
(Date:12/2/2008)...ERS, Ind., Dec. 2 A number of rece...in childhood obesity, the health risks in,overwei...ue of cereals and,other foods kids consume. Yet ...fers all natural, freeze-dried real fruit products...ut also provide most, if not all, of the daily fru...
Breaking Medicine News(10 mins):Health News:Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 3Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 2Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 3Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 4Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 3
...en spending precious time online, which you fear w...r fears // for a while and read this. A Northweste...e spent valuable 7 years, observing an online club...ears. According to Justine Cassel, professor of co...
...ate professor of surgery and researchers at the Un...unology and Transplantation has successfully rever...ells from pigs. // Suppression of graft rejectio...unosuppressive protocol. They have reversed the ty...
...st the use of Teflon. The Environmental Protection... main ingredient used to make the substance nonsti...nd that when the coated cookware was heated to mor...son faces an unknown risk of cancer. Teflon was ...
...ks between land-based pollution, and diseases in o...ians, and veterinarians, that implies an unhealthy... Sandifer, Chief Scientist for the new Oceans and ...al Oceanic and Atmospheric Administration (NOAA),"...
Other Medicine News:Health News:Youngsters, now have a good reason to interact online 2Health News:Diabetes cure can be achieved using pig islets 2
(Date:12/1/2008)... Dec. 1 GeoVax Labs, Inc...otechnology company developing,human vaccines for...Virus) and,other infectious agents, announced tod...Trials will take place in twelve sites across Nort...n collaboration with The National Institutes of,H...
(Date:11/28/2008)...OLIS, Nov. 28 Eli Lilly ...lemental New Drug Application (sNDA) from,the U.S...R) (duloxetine HCl),for the management of chronic...,the first half of 2009, adding data from a recent...itis pain of the knee. , The decision does ...
(Date:11/25/2008)...awareness can improve recovery , , Audio an...available on the Mayo Clinic News Blog. Please see... , ROCHESTER, Minn., Nov. 25 /PRNewswire-USNew...stroke patients don,t think they,re having a strok...til their condition worsens. The findings appear i...
(Date:11/25/2008)...E, Calif., Nov. 25 Pharm...that the company has completed a Phase 1,clinical...in-class,small-molecule Factor VIIa inhibitor. Th...unteers to evaluate the safety and pharmacologic e...I-27483 resulted in a linear dose,response in the...
Breaking Medicine Technology:GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Bioheart Founder Howard J Leonhardt Becomes Chairman of the Board of Directors 4022 1Bioheart Founder Howard J Leonhardt Becomes Chairman of the Board of Directors 4022 2Bioheart Founder Howard J Leonhardt Becomes Chairman of the Board of Directors 4022 3Bioheart Founder Howard J Leonhardt Becomes Chairman of the Board of Directors 4022 4NASA satellite measures pollution from east Asia to North America 2532 1NASA satellite measures pollution from east Asia to North America 2532 2NASA satellite measures pollution from east Asia to North America 2532 3Evanston Northwestern Healthcare Researchers Explain Effects of Large Scale Universal MRSA Surveillance Program That Supports Expanded Intervention 1543 1Evanston Northwestern Healthcare Researchers Explain Effects of Large Scale Universal MRSA Surveillance Program That Supports Expanded Intervention 1543 2Evanston Northwestern Healthcare Researchers Explain Effects of Large Scale Universal MRSA Surveillance Program That Supports Expanded Intervention 1543 3Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 1Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 2Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 3Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 4Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 5Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 6Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 7Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 8
... Reported Safety & Tolerability Profile,in Sub...CHICAGO, June 25 /PRNewswire-FirstCall/ -- Phase I...of the American Diabetes,Association demonstrated ...dase-4 (DPP-4) in development by Bristol-Myers,Squ...), in,combination with metformin, exhibited a stat...
...Unique Mechanism of Action and Broad Potential for...A, Calif., June 26, 2007 (PRIME NEWSWIRE) -- Avige... innovating therapeutics,for the treatment of neur...pinion on Investigational Drugs has published an a...(ibudilast), a potential,first-in-class, non-opioi...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 2Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 3Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 4Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 5
Indicated for treatment of patella instability
OmoTrain is a unique support for the shoulder that promotes mobility and limits rotation.
... someone suffers an episode of acute low back pain...ickly restores functional mobility by providing po...,With just a few sizes that correspond directly to... will reduce inventory requirements while simplify...
Shoulder Immobilizer with Body Strap Navy blue cotton. Thumb look helps keep hand in neutral position. Padded, 2" blue pile material laminated to foam shoulder and body strap. Fits left or right. 5/p
Medicine Products: